Statistics
Publications
3
Citations
163
H-Index
3
Active since
2022
Benjamin F. Springer is an author at Dana-Farber Cancer Institute specializing in molecular oncology, cancer immunotherapy, and oncogenic signaling pathways.
Publications per year
2022–2023
3
3
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Shunsuke Kitajima, Tetsuo Tani, Benjamin F. Springer et al. · Cancer Cell · 2022 · 101 citations · Full text
Medicine, Cancer Biology, Oncology +11
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer
Ryohei Yoshida, Maria Saigí, Tetsuo Tani et al. · Cancer Research · 2022 · 37 citations · Full text
Medicine, Oncology, Pharmacology +17
1–3 of 3